[1] WALKER PA, SHAH SK, HARTING MT, et al. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech. 2009;2(1-2):23-38.
[2] HO AD, WAGNER W, FRANKE W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy. 2008;10(4):320-330.
[3] UCCELLI A, MORETTA L, PISTOIA V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726-736.
[4] FRIEDENSTEIN AJ, PETRAKOVA KV, KUROLESOVA AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation.1968;6(2):230-247.
[5] LUGER D, LIPINSKI MJ, WESTMAN PC, et al. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy. Circ Res. 2017;120(10):1598-1613.
[6] CHEN Y, ZHAO Y, CHEN W, et al. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction. Stem Cell Res Ther. 2017;8(1):268.
[7] ZHOU P, LIU Z, LI X, et al. Migration ability and Toll-like receptor expression of human mesenchymal stem cells improves significantly after three-dimensional culture. Biochem Biophys Res Commun. 2017; 491(2):323-328.
[8] LIANG L, LI Z, MA T, et al. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats. Cell Transplant. 2017;26(1):45-61.
[9] ISHIZAKA S, HORIE N, SATOH K, et al. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke. 2013;44(3):720-726.
[10] GHAZAVI H, HOSEINI SJ, EBRAHIMZADEH-BIDESKAN A, et al. Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose- Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model. Stem Cell Rev. 2017;13(5):670-685.
[11] OH SK, CHOI KH, YOO JY, et al. A Phase III Clinical Trial Showing Limited Efficacy of Autologous Mesenchymal Stem Cell Therapy for Spinal Cord Injury. Neurosurgery. 2016;78(3):436-447.
[12] KIM HS, LEE JH, ROH KH, et al. Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies. Stem Cells. 2017;35(1):248-255.
[13] WONG SP, ROWLEY JE, REDPATH AN, et al. Pericytes, mesenchymal stem cells and their contributions to tissue repair. Pharmacol Ther. 2015; 151:107-120.
[14] ANKRUM JA, ONG JF, KARP JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252-260.
[15] CUNNINGHAM CJ, REDONDO-CASTRO E, ALLAN SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38(8):1276-1292.d
[16] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-317.
[17] XU L, LIU Y, SUN Y, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther. 2017;8(1):275.
[18] COOPER GM, DURHAM EL, CRAY JJ JR, et al. Direct comparison of progenitor cells derived from adipose, muscle, and bone marrow from wild-type or craniosynostotic rabbits. Plast Reconstr Surg. 2011;127(1): 88-97.
[19] PERS YM, MAUMUS M, BONY C, et al. Contribution of microRNAs to the immunosuppressive function of mesenchymal stem cells. Biochimie. 2018;155:109-118.
[20] ZHU Y, ZHANG K, ZHAO R, et al. Bone regeneration with micro/nano hybrid-structured biphasic calcium phosphate bioceramics at segmental bone defect and the induced immunoregulation of MSCs. Biomaterials. 2017;147:133-144.
[21] UCHIDA S, HAYAKAWA K, OGATA T, et al. Treatment of spinal cord injury by an advanced cell transplantation technology using brain-derived neurotrophic factor-transfected mesenchymal stem cell spheroids. Biomaterials. 2016;109:1-11.
[22] MAUMUS M, JORGENSEN C, NOËL D. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie. 2013;95(12):2229-2234.
[23] MEIRELLES LDA S, FONTES AM, COVAS DT, et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5-6):419-427.
[24] GHANNAM S, BOUFFI C, DJOUAD F, et al. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther. 2010;1(1):2.
[25] DE ALMEIDA DC, DONIZETTI-OLIVEIRA C, BARBOSA-COSTA P, et al. In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury. Clin Biochem Rev. 2013;34(3):131-144.
[26] MILADPOUR B, RASTI M, OWJI AA, et al. Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro. J Endocrinol Invest. 2017;40(5):513-521.
[27] MEYER MB, BENKUSKY NA, SEN B, et al. Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells. J Biol Chem. 2016;291(34):17829-17847.
[28] GUO L, GE J, ZHOU Y, et al. Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection. Stem Cells Dev. 2014;23(9):978-989.
[29] ZHOU Z, CHEN Y, ZHANG H, et al. Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy. 2013;15(4):434-448.
[30] HO SS, HUNG BP, HEYRANI N, et al. Hypoxic Preconditioning of Mesenchymal Stem Cells with Subsequent Spheroid Formation Accelerates Repair of Segmental Bone Defects. Stem Cells. 2018;36(9): 1393-1403.
[31] HUANG GS, DAI LG, YEN BL, et al. Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials. 2011;32(29):6929-6945.
[32] GÜNTER J, WOLINT P, BOPP A, et al. Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment. Stem Cells Int. 2016;2016:9098523.
[33] SALEH FA, WHYTE M, GENEVER PG. Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater. 2011;22:242-257.
[34] DROMARD C, BOURIN P, ANDRÉ M, et al. Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres. Exp Cell Res. 2011;317(6):770-780.
[35] KAPUR SK, WANG X, SHANG H, et al. Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids. Biofabrication. 2012;4(2):025004.
[36] CESARZ Z, TAMAMA K. Spheroid Culture of Mesenchymal Stem Cells. Stem Cells Int. 2016;2016:9176357.
[37] LARANJEIRA P, PEDROSA M, PEDREIRO S, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3.
[38] BARTOSH TJ, YLÖSTALO JH, MOHAMMADIPOOR A, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107(31): 13724-13729.
[39] NAKAMURA M, OKANO H. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res. 2013;23(1): 70-80.
[40] MADRIGAL M, RAO KS, RIORDAN NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260.
[41] JOSHI J, BRENNAN D, BEACHLEY V, et al. Cardiomyogenic differentiation of human bone marrow-derived mesenchymal stem cell spheroids within electrospun collagen nanofiber mats. J Biomed Mater Res A. 2018;106(12):3303-3312.
[42] LEE WY, CHANG YH, YEH YC, et al. The use of injectable spherically symmetric cell aggregates self-assembled in a thermo-responsive hydrogel for enhanced cell transplantation.Biomaterials. 2009;30(29): 5505-5513.
[43] KIM JH, PARK IS, PARK Y, et al. Therapeutic angiogenesis of three-dimensionally cultured adipose-derived stem cells in rat infarcted hearts. Cytotherapy. 2013;15(5):542-556.
[44] BARTOSH TJ, YLÖSTALO JH, MOHAMMADIPOOR A, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107(31):13724-13729.
[45] LEE BH, PARK JN, LEE EJ, et al. Therapeutic Efficacy of Spherical Aggregated Human Bone Marrow-Derived Mesenchymal Stem Cells Cultured for Osteochondral Defects of Rabbit Knee Joints. Am J Sports Med. 2018;46(9):2242-2252.
[46] MURPHY KC, HOCH AI, HARVESTINE JN, et al. Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α2β1 Signaling. Stem Cells Transl Med. 2016;5(9):1229-1237.
[47] SANTOS JM, CAMÕES SP, FILIPE E, et al. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing. Stem Cell Res Ther. 2015;6:90.
[48] BORGES FT, SCHOR N. Regenerative medicine in kidney disease: where we stand and where to go. Pediatr Nephrol. 2018;33(9):1457-1465.
[49] XU Y, SHI T, XU A, et al. 3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney. J Cell Mol Med. 2016;20(7):1203-1213.
[50] SUN Y, WANG Y, ZHOU L, et al. Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia- reperfusion injury in rats. Sci Rep. 2018;8(1):2518.
[51] ZHANG X, HU MG, PAN K, et al. 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose-Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis. Stem Cells Int. 2016;2016:4626073.
|